After 26-year-old Chicago patient Iris Di Cesare lost her job during treatment for stage 3 invasive ductal carcinoma, her out-of-pocket breast cancer costs climbed above $20,000 before Northwestern social workers helped her secure Illinois state coverage. The clinical implication: even insured young adults with malignant neoplasm can face coverage gaps that threaten medication adherence, follow-up care and treatment continuity.

The Move

• Di Cesare was diagnosed in 2022 with stage 3, hormone-positive invasive ductal carcinoma after noticing a rapidly enlarging breast lump and skin changes.

• Her treatment included chemotherapy, a nipple-sparing double mastectomy, lymph node removal, 25 days of radiation and multiple reconstruction surgeries.

• After radiation and the start of long-term medications, she lost her job, her insurance ended sooner than expected, and hospital social workers connected her to Illinois public coverage and the Illinois Breast and Cervical Cancer Program.

Why it Matters for Care

• Financial toxicity can become a direct care barrier: patients may delay filling prescriptions, postpone follow-up visits or skip recommended treatment because of cost.

• For clinicians, new cancer diagnoses should trigger early screening for insurance instability, employment risk, transportation needs and drug affordability — especially in younger patients aging off family coverage.

• Bedside takeaway: documenting symptoms early, expediting social work referral and discussing assistance programs can help preserve treatment adherence.

Between the Lines

• The story underscores how U.S. cancer care financing is often tied to employment, leaving patients vulnerable when illness collides with job loss.

• American Cancer Society and ACS CAN CEO Shane Jacobson said many patients draw down savings, take on debt or cut household spending; average annual out-of-pocket costs exceeded $6,000 for patients with breast, colorectal and lung cancers.

• Nonmedical costs — transportation, lodging and childcare — can compound toxicity even for insured patients, with nearly half of cancer patients carrying medical debt.

What to Watch

• Whether clinicians and health systems build more routine workflows for financial navigation at diagnosis and during transitions in employment or insurance.

• State and federal policy debates over Medicaid, Marketplace coverage, disability supports and other safety-net programs that can determine whether treatment gaps widen or close.

• How advocacy groups and cancer centers push earlier patient education on warning symptoms, baseline breast awareness and available coverage resources.

Source: NBC News Health